Logo IRSC-EMAAD

Description du projet

Contenu du projet

Membres de l'équipe

Structure de l'équipe

Accord de recherche

Partenaires / Liens

Nouvelles

 

 

 

 

banderouge
Devenir membre

PUBLICATIONS

 

PUBLICATIONS DE L'EQUIPE (CENTREES SUR LE PROJET)

2006

Leduc C, Coonishish J, Haddad P, Cuerrier A (2006)Plants used by the Cree Nation of Eeyou Istchee (Quebec, Canada) for the treatment of diabetes: A novel approach in quantitative ethnobotany.J Ethnopharmacol. 2006 Apr 21;105(1-2):55-63. Epub 2005 Nov 16.

Spoor DC, Martineau LC, Leduc C, Benhaddou-Andaloussi A, Meddah B, Harris C, Burt A, Fraser MH, Coonishish J, Joly E, Cuerrier A, Bennett SA, Johns T, Prentki M, Arnason JT, Haddad PS (2006).
Selected plant species from the Cree pharmacopoeia of northern Quebec possess anti-diabetic potential. Can J Physiol Pharmacol. 2006 Aug-Sep;84(8-9):847-58.

2007

Fraser MH, Cuerrier A, Haddad PS, Arnason JT, Owen PL, Johns T (2007).
Medicinal plants of Cree communities (Québec, Canada): antioxidant activity of plants used to treat type 2 diabetes symptoms. Can J Physiol Pharmacol. 2007 Nov;85(11):1200-14.

2008

Harris CS, Lambert J, Saleem A, Coonishish J, Martineau L, Cuerrier A, Haddad PS, Arnason JT, Bennett SAL (2008) Anti-diabetic activity of extracts from needle, bark, and cone of picea glauca: Organ-specific protection from glucose toxicity and glucose deprivation. Pharmaceutical Biology, 46: 124-134. (PDF) Author Posting. (c) Informa Health Care USA, 2008. This is the author's version of the work. It is posted here by permission of Informa Health Care USA, 2008 for personal use, not for redistribution. The definitive version was published in Pharmaceutical Biology, Volume 46 Issue 1, January 2008. doi:10.1080/13880200701735080 (http://dx.doi.org/10.1080/13880200701735080)

2009

Harbilas D, Martineau LC, Harris CS, Adeyiwola-Spoor DC, Saleem A, Lambert J, Caves D, Johns T, Prentki M, Cuerrier A, Arnason JT, Bennett SA, Haddad PS (2009). Evaluation of the antidiabetic potential of selected medicinal plant extracts from the Canadian boreal forest used to treat symptoms of diabetes: part II. Can J Physiol Pharmacol. 2009 Jun;87(6):479-92.

Martineau LC, Adeyiwola-Spoor DC, Vallerand D, Afshar A, Arnason JT, Haddad PS (2009).
Enhancement of muscle cell glucose uptake by medicinal plant species of Canada's native populations is mediated by a common, Metformin-like mechanism. J Ethnopharmacol. 2009 Oct 25. [Epub ahead of print]

Tam TW, Liu R, Arnason JT, Krantis A, Staines WA, Haddad PS, Foster BC (2009). Actions of ethnobotanically selected Cree anti-diabetic plants on human cytochrome P450 isoforms and flavin-containing monooxygenase 3. J Ethnopharmacol. 2009 Oct 29;126(1):119-26.

Vianna R, Brault A, Martineau LC, Couture R, Arnason JT, Haddad PS (2009). In Vivo Anti-Diabetic Activity of the Ethanolic Crude Extract of Sorbus decora C.K.Schneid. (Rosacea): A Medicinal Plant Used by Canadian James Bay Cree Nations to Treat Symptoms Related to Diabetes. Evid Based Complement Alternat Med. 2009 Nov 3. [Epub ahead of print]

Beaulieu LP, Harris CS, Saleem A, Cuerrier A, Haddad PS, Martineau LC, Bennett SA, Arnason JT (2009).
Inhibitory effect of the cree traditional medicine wiishichimanaanh (Vaccinium vitis-idaea) on advanced glycation endproduct formation: identification of active principles. Phytother Res. 2009 Nov 19. [Epub ahead of print]

2010

Eid HM, Vallerand D, Muhammad A, Durst T, Haddad PS, Martineau LC (2010). Structural constraints and the importance of lipophilicity for the mitochondrial uncoupling activity of naturally occurring caffeic acid esters with potential for the treatment of insulin resistance. Biochem Pharmacol. 2010 Feb 1;79(3):444-54. Epub 2009 Sep 2


PUBLICATIONS AFFILIÉES (ÉTUDES MÉTHODOLOGIQUES ET PÉRIPHÉRIQUES)



2007

Harris CS*, Burt A, Saleem A, Le PM, Martineau L, Haddad PS, Bennett SAL, Arnason JT (2007).
A single HPLC-DAD/APCI-MS method fors quantitative comparison of compounds found in leaf, stem, root and fruit extracts of lowbush blueberry, Vaccinium angustifolium Ait. Phytochemical Analysis, 18: 161-169 (PDF)

Ryan SD, Harris CS, Mo F, Lee H, Hou ST, Bazan NG, Haddad PS, Arnason JT, Bennett SA. Platelet activating factor-induced neuronal apoptosis is initiated independently of its G-protein coupled PAF receptor and is inhibited by the benzoate orsellinic acid. J Neurochem. 2007 Oct;103(1):88-97.

Harris CS, Mo F, Migahed L, Chepelev L, Haddad PS, Wright JS, Willmore WG, Arnason JT, Bennett SA.
Plant phenolics regulate neoplastic cell growth and survival: a quantitative structure-activity and biochemical analysis. Can J Physiol Pharmacol. 2007 Nov;85(11):1124-38.


2008

Farsi DA, Harris CS, Reid L, Bennett SA, Haddad PS, Martineau LC, Arnason JT. Inhibition of non-enzymatic glycation by silk extracts from a Mexican land race and modern inbred lines of maize (Zea mays). Phytother Res. 2008 Jan;22(1):108-12.

Ryan SD, Harris CS, Mo F, Lee H, Hou ST, Bazan NG, Haddad PS, Arnason JT, Bennett SA. Platelet activating factor-induced neuronal apoptosis is initiated independently of its G-protein coupled PAF receptor and is inhibited by the benzoate orsellinic acid. J Neurochem. 2007 Oct;103(1):88-97.

Owen PL, Martineau LC, Caves D, Haddad PS, Matainaho T, Johns T. Consumption of guava (Psidium guajava L) and noni (Morinda citrifolia L) may protect betel quid-chewing Papua New Guineans against diabetes.Asia Pac J Clin Nutr. 2008;17(4):635-43.


2009

McIntyre KL, Harris CS, Saleem A, Beaulieu LP, Ta CA, Haddad PS, Arnason JT (2009).
Seasonal phytochemical variation of anti-glycation principles in lowbush blueberry (Vaccinium angustifolium). Planta Med. 2009 Feb;75(3):286-92.

 
 
 
retour au haut de la page